Study identifies key contamination source during ATMP manufacture
European Pharmaceutical Review
JUNE 5, 2023
A two-year study monitoring microbial contamination of adipose tissue-derived stem cells (ADSC)-based advanced therapy medicinal products (ATMP) during manufacture , showed over 40 percent of lipoaspirate samples were contaminated with thirteen different microorganisms. Among the collected samples, only 248 (1.12 percent to 36.4
Let's personalize your content